These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 26585336)
1. A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia. Henk HJ; Paoli CJ; Gandra SR Adv Ther; 2015 Nov; 32(11):1104-16. PubMed ID: 26585336 [TBL] [Abstract][Full Text] [Related]
2. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study. Fox KM; Wang L; Gandra SR; Quek RGW; Li L; Baser O BMC Cardiovasc Disord; 2016 Jan; 16():13. PubMed ID: 26769473 [TBL] [Abstract][Full Text] [Related]
3. Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data. Hallberg S; Gandra SR; Fox KM; Mesterton J; Banefelt J; Johansson G; Levin LÅ; Sobocki P Eur J Health Econ; 2016 Jun; 17(5):591-601. PubMed ID: 26077550 [TBL] [Abstract][Full Text] [Related]
4. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. Danese MD; Gleeson M; Griffiths RI; Catterick D; Kutikova L J Med Econ; 2017 Sep; 20(9):931-937. PubMed ID: 28635339 [TBL] [Abstract][Full Text] [Related]
5. Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012. Quiros-Roldan E; Raffetti E; Focà E; Brianese N; Ferraresi A; Paraninfo G; Pezzoli MC; Bonito A; Magoni M; Scarcella C; Castelli F AIDS Care; 2016 Dec; 28(12):1551-1558. PubMed ID: 27321070 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF; Hsiao FY; Wen YW; Tsai YW Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [TBL] [Abstract][Full Text] [Related]
7. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study. Djamali A; Singh T; Melamed ML; Stein JH; Aziz F; Parajuli S; Mohamed M; Garg N; Mandelbrot D; Wesson DE; Astor BC Am J Kidney Dis; 2019 Apr; 73(4):476-485. PubMed ID: 30704880 [TBL] [Abstract][Full Text] [Related]
8. High cardiovascular event rates occur within the first weeks of starting hemodialysis. Eckardt KU; Gillespie IA; Kronenberg F; Richards S; Stenvinkel P; Anker SD; Wheeler DC; de Francisco AL; Marcelli D; Froissart M; Floege J; Kidney Int; 2015 Nov; 88(5):1117-25. PubMed ID: 25923984 [TBL] [Abstract][Full Text] [Related]
9. Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. Banefelt J; Hallberg S; Fox KM; Mesterton J; Paoli CJ; Johansson G; Levin LÅ; Sobocki P; Gandra SR Eur J Health Econ; 2016 Dec; 17(9):1117-1124. PubMed ID: 26607457 [TBL] [Abstract][Full Text] [Related]
10. The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study. Hsu UH; Lin YT; Chiang BL J Formos Med Assoc; 2024 Apr; 123(4):478-486. PubMed ID: 37813767 [TBL] [Abstract][Full Text] [Related]
11. Determining initial and follow-up costs of cardiovascular events in a US managed care population. Chapman RH; Liu LZ; Girase PG; Straka RJ BMC Cardiovasc Disord; 2011 Mar; 11():11. PubMed ID: 21410963 [TBL] [Abstract][Full Text] [Related]
12. Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia. Punekar RS; Fox KM; Richhariya A; Fisher MD; Cziraky M; Gandra SR; Toth PP Clin Cardiol; 2015 Aug; 38(8):483-91. PubMed ID: 26100722 [TBL] [Abstract][Full Text] [Related]
13. Association of Longitudinal Patterns of Habitual Sleep Duration With Risk of Cardiovascular Events and All-Cause Mortality. Wang YH; Wang J; Chen SH; Li JQ; Lu QD; Vitiello MV; Wang F; Tang XD; Shi J; Lu L; Wu SL; Bao YP JAMA Netw Open; 2020 May; 3(5):e205246. PubMed ID: 32442289 [TBL] [Abstract][Full Text] [Related]
14. Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. Danese MD; Gleeson M; Kutikova L; Griffiths RI; Azough A; Khunti K; Seshasai SR; Ray KK BMJ Open; 2016 Aug; 6(8):e011805. PubMed ID: 27496237 [TBL] [Abstract][Full Text] [Related]
15. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database. Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183 [TBL] [Abstract][Full Text] [Related]
16. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887 [TBL] [Abstract][Full Text] [Related]
18. Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands. Heintjes E; Kuiper J; Lucius B; Penning-van Beest F; Kutikova L; Liem A; Herings R Curr Med Res Opin; 2017 Jan; 33(1):91-100. PubMed ID: 27646783 [TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia and Medical Expenditures by Cardiovascular Disease Status in US Adults. Zhang D; Wang G; Fang J; Mercado C Med Care; 2017 Jan; 55(1):4-11. PubMed ID: 27787352 [TBL] [Abstract][Full Text] [Related]